Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Norwegian Cruise Line (NCLH) Outperforms Broader Market: What You Need to Know
Norwegian Cruise Line (NCLH) Outperforms Broader Market: What You Need to Know

In the latest trading session, Norwegian Cruise Line (NCLH) closed at $22.78, marking a +2.06% move from the previous day. This move outpaced the S&P 500's daily gain of 0.19%. At the same time, the

INCY's Phase III Monjuvi Study Meets Key Goals in First-Line Lymphoma
INCY's Phase III Monjuvi Study Meets Key Goals in First-Line Lymphoma

Incyte INCY announced positive top-line results from a late-stage lymphoma study of Monjuvi/Minjuvi (tafasitamab), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, in the

Implenia wins major contracts for new double-track line – cutting-edge railway infrastructure between Zurich and Winterthur: https://mailing-ircockpit.eqs.com/crm-mailing/4a8f949c-17dc-11e9-a2a1-2c44fd856d8c/fc0b8f75-e330-438e-b5a8-48753388a04d/f3e494e5-0a83-4a6e-abea-599e5f285b43/SBB-MSZW-Winterthur-Bruecke-Neumuehle.jpg
Implenia wins major contracts for new double-track line – cutting-edge railway infrastructure between Zurich and Winterthur
Implenia wins major contracts for new double-track line – cutting-edge railway infrastructure between Zurich and Winterthur
HELE Q3 Earnings Meet Estimates, Home & Outdoor Sales Decline Y/Y
HELE Q3 Earnings Meet Estimates, Home & Outdoor Sales Decline Y/Y

Helen of Troy Limited (HELE) reported mixed third-quarter fiscal 2026 results, with the top line beating the Zacks Consensus Estimate and the bottom line matching the same. Both net sales and

4 Stocks With Solid Net Profit Margins to Boost Portfolio Return: https://staticx-tuner.zacks.com/images/articles/main/9b/128209.webp
4 Stocks With Solid Net Profit Margins to Boost Portfolio Return

Net profit, also referred to as the bottom line, is one of the key tools to determine the financial health of an enterprise. The metric demonstrates a company’s ability to convert per-dollar sales

Coty E-Commerce Grows Mid-Single Digits: Is Digital the Backbone?
Coty E-Commerce Grows Mid-Single Digits: Is Digital the Backbone?

Coty Inc.’s (COTY) first-quarter fiscal 2026 performance highlights the growing strategic relevance of e-commerce, even as it navigates broader top-line pressure from trade destocking. In the fiscal

Here's Why Investors Should Bet on Wabtec Stock Right Now
Here's Why Investors Should Bet on Wabtec Stock Right Now

Westinghouse Air Brake Technologies WAB, operating as Wabtec, has seen its top line bolstered by robust backlog growth. This, in turn, has boosted the company’s overall performance

Medifast New Product Line Planned: Can Innovation Reignite Demand?
Medifast New Product Line Planned: Can Innovation Reignite Demand?

Medifast, Inc. MED is strategically transitioning beyond its traditional identity as a weight-loss company toward becoming a broader leader in metabolic health. As part of this evolution, the

PRU Stock Trades at Discount to Industry at 7.62X: Time to Hold?
PRU Stock Trades at Discount to Industry at 7.62X: Time to Hold?

Prudential Financial Inc. PRU shares are trading at a discount compared to the Zacks Multi-line Insurance industry. Its shares are currently trading at a price-to-earnings multiple of 7.62, which is

NCLH's Profitability Profile Improves: Is the Turnaround Taking Hold?
NCLH's Profitability Profile Improves: Is the Turnaround Taking Hold?

Norwegian Cruise Line Holdings Ltd. NCLH is positioning 2026 as a pivotal year in its multi-year recovery, with management signaling that operational improvements are beginning to translate into

Here's How AbbVie's Neuroscience Portfolio Is Aiding Top-line Growth
Here's How AbbVie's Neuroscience Portfolio Is Aiding Top-line Growth

AbbVie ABBV has built a substantial neuroscience franchise. While the segment was initially anchored by Botox Therapeutic and the depression drug Vraylar, its offerings now include the oral migraine

CCL vs. NCLH: Which Cruise Stock Is Better Positioned for 2026?
CCL vs. NCLH: Which Cruise Stock Is Better Positioned for 2026?

Carnival Corporation & plc CCL and Norwegian Cruise Line Holdings Ltd. NCLH are both entering 2026 with strong demand trends, improving execution and destination-driven strategies that are reshaping

Hormel Foods Foodservice Growth: Is This a Key Earnings Lever?
Hormel Foods Foodservice Growth: Is This a Key Earnings Lever?

Hormel Foods Corporation’s (HRL) Foodservice segment continues to stand out as a structurally important earnings driver, underpinned by measurable top-line momentum and a growing mix of value-added

Advanced Micro Devices Is the Most Compelling AI Trade for 2026: https://www.marketbeat.com/logos/articles/med_20251230144621_advanced-micro-devices-is-the-most-compelling-ai-t.png
Advanced Micro Devices Is the Most Compelling AI Trade for 2026

Advanced Micro Devices (NASDAQ: AMD) appears to be one of the most compelling AI setups for 2026, due to the company's position in the GPU market and the expected launch of its MI450 line, which

Here's Why Investors Should Give Old Dominion Stock a Miss Now
Here's Why Investors Should Give Old Dominion Stock a Miss Now

Old Dominion Freight Line, Inc. (ODFL is currently mired in multiple headwinds, which, we believe, have made it an unimpressive investment option.

Let’s delve deeper.

Southward Earnings Estimate

AXAHY vs. ZURVY: Which Stock Is the Better Value Option?
AXAHY vs. ZURVY: Which Stock Is the Better Value Option?

Investors interested in Insurance - Multi line stocks are likely familiar with Axa Sa (AXAHY) and Zurich Insurance Group Ltd. (ZURVY). But which of these two stocks offers value investors a better

Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings?
Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings?

Amicus Therapeutics FOLD has made solid progress with its lead marketed product, Galafold (migalastat), which generates the majority of the company’s revenues.

Galafold is approved for treating

AAR Q2 Earnings Surpass Estimates, Sales Increase Year Over Year
AAR Q2 Earnings Surpass Estimates, Sales Increase Year Over Year

AAR Corp. AIR reported second-quarter fiscal 2026 adjusted earnings of $1.18 per share, which topped the Zacks Consensus Estimate of $1.02 by 15.7%. The bottom line also improved 31.1% from the

NIO Crosses 1M Vehicle Production Milestone, Expands Tech Push
NIO Crosses 1M Vehicle Production Milestone, Expands Tech Push

NIO Inc. NIO marked a major production milestone as its one-millionth mass-produced vehicle rolled off the assembly line at the NIO Advanced Manufacturing Xinqiao Phase II facility in Hefei, per

ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies
ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies

Shares of Alumis ALMS surged 95.3% on Jan. 6, after the company announced positive top-line data from its two phase III studies — ONWARD1 and ONWARD2 — which evaluated its pipeline candidate